Liquidia Corp’s Stock Soars 15% as Yutrepia Launch Clears Legal Hurdles
Liquidia Corp’s stock surged 15% after a court cleared the way for the launch of its drug Yutrepia, a significant milestone for the biotech company.
2 minutes to read
Liquidia Corp’s Stock Soars as Court Clears Yutrepia Launch Amid Regulatory Shifts
Liquidia Corp’s stock surged 15% after a court cleared the way for the launch of its key product Yutrepia, ahead of the company’s upcoming financial results announcement on May 8, 2025.
2 minutes to read